Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenal Gland Disorders

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

The Endocrine System

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Longitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome.

The Journal of clinical endocrinology and metabolism·2025

Same author

Genome-wide association study of plasma amino acids and Mendelian randomization for cardiometabolic traits.

Scientific reports·2025

Same author

A population-based urinary and plasma metabolomics study of environmental exposure to cadmium.

Environmental health and preventive medicine·2024

Same author

Optimal index for detecting splenic involvement on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diffuse large B-cell lymphoma.

Medicine·2024

Same author

Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers.

Journal of atherosclerosis and thrombosis·2024

Same author

Reliability of Time-Series Plasma Metabolome Data over 6 Years in a Large-Scale Cohort Study.

Metabolites·2024

Search research articles

Related Experiment Video

Updated: May 24, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

[Endocrine disorders and metabolic disorders].

Takamasa Matsunaga¹, Masaru Tomita, Naohisa Uchimura

¹Department of Neuropsychiatry, Kurume University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|March 15, 2012

Summary

Psychiatric symptoms are common in endocrine and metabolic disorders. While psychotropic medications can manage symptoms, their impact on the underlying conditions requires careful risk-benefit consideration.

Related Experiment Videos

Last Updated: May 24, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Area of Science:

Endocrinology
Metabolic Disorders
Psychiatry

Context:

Psychiatric symptoms frequently manifest alongside endocrine and metabolic disorders.
Conditions like thyroid disease, adrenal disorders, parathyroid disease, diabetes, and electrolyte disturbances are common culprits.
The interplay between these conditions and mental health is well-established.

Purpose:

To review common endocrine and metabolic disorders associated with psychiatric symptoms.
To focus on the appropriate use of psychotropic medications in these patients.
To highlight the need for careful consideration of medication effects on underlying conditions.

Summary:

Psychiatric symptoms are recognized in endocrine and metabolic disorders.
Commonly implicated conditions include thyroid disease, adrenal disorders, parathyroid disease, diabetes, and electrolyte disturbances.
Psychotropic medications are recommended for moderate to severe symptoms, but their potential impact on the background endocrine/metabolic disorders must be assessed.
Individualized risk-benefit analysis is crucial before prescribing psychotropic medication.

Impact:

Provides guidance on psychotropic medication use in patients with endocrine/metabolic disorders.
Emphasizes the importance of considering medication side effects on underlying physiological conditions.
Highlights the need for a balanced approach to managing psychiatric symptoms in this patient population.